Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from China Shineway Pharmaceutical Group Limited ( (HK:2877) ).
China Shineway Pharmaceutical Group Limited has announced the appointment of Ms. Wang Guihua as a member of its nomination committee, effective from June 10, 2025. This strategic appointment is expected to enhance the company’s governance structure and strengthen its leadership, potentially impacting its market positioning positively.
More about China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and sale of traditional Chinese medicine and other pharmaceutical products. The company is known for its emphasis on integrating traditional Chinese medicine with modern pharmaceutical practices.
Average Trading Volume: 1,309,305
Technical Sentiment Signal: Hold
Current Market Cap: HK$5.65B
For detailed information about 2877 stock, go to TipRanks’ Stock Analysis page.